Drug Shortage Report for SODIUM BICARBONATE INJECTION USP
Report ID | 43092 |
Drug Identification Number | 00038083 |
Brand name | SODIUM BICARBONATE INJECTION USP |
Common or Proper name | SODIUM BICARBONATE LIFESHIELD |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM BICARBONATE |
Strength(s) | 75MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 10 x 50mL |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-05-04 |
Actual start date | |
Estimated end date | |
Actual end date | 2018-05-16 |
Shortage status | Resolved |
Updated date | 2018-05-17 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-03-16 | English | Compare |
v2 | 2018-03-16 | French | Compare |
v3 | 2018-05-05 | English | Compare |
v4 | 2018-05-17 | English | Compare |
v5 | 2018-05-17 | French | Compare |
Showing 1 to 5 of 5